Clinical trial
Cardiovascular Disease Screening
NCT00483951 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00483951 |
|---|---|
| Title | Cardiovascular Disease Screening |
| Official title | Suburban/NHLBI Cardiovascular Disease Screening Protocol |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Congenital Heart Disease, Atherosclerosis, Myocardial Ischemia, Myocardial Infarction, Acquired Heart Disease |
| Intervention type | Device |
| Interventions | Toshiba Aquilion ONE CT, SWiemens MRI scanner |
| Enrollment | 1,325 |
| Start date | Jan 28, 2008 |
| Primary completion | Nov 3, 2020 |
| Completion | Nov 3, 2020 |
| First posted | Jun 8, 2007 |
| Last update posted | Jul 29, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: